Lv5
848 积分 2021-10-28 加入
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
4天前
已完结
Trial of the Oral PCSK9 Inhibitor Enlicitide
4天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
15天前
已完结
Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
24天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
24天前
已完结
Pharmacological treatments for moderate-to-severe ulcerative colitis: a systematic review and Bayesian network meta-analysis
24天前
已完结
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity
1个月前
已完结
Targeting neuropeptide Y receptors for obesity management: Mechanistic insights, pharmacological advances, and translational challenges
1个月前
已完结
Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS - and RAF -Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass
2个月前
已完结
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS)
2个月前
已完结
皖公网安备34019202002308
